Nu Skin Company Insiders

NUS Stock  USD 12.47  0.28  2.20%   
Nu Skin's insiders are aggressively selling. The analysis of insiders' sentiment of trading Nu Skin Enterprises stock suggests that vertually all insiders are panicking at this time. Nu Skin employs about 3.7 K people. The company is managed by 28 executives with a total tenure of roughly 232 years, averaging almost 8.0 years of service per executive, having 132.14 employees per reported executive.
Truman Hunt  CEO
CEO and President and Director
Ryan Napierski  CEO
President, Chief Executive Officer, Director

Nu Skin's Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-03-25Andrew D LipmanDisposed 2000 @ 12.32View
2024-02-26Andrew D LipmanDisposed 2000 @ 12.46View
2024-01-25Andrew D LipmanDisposed 2000 @ 18.55View
2023-12-26Andrew D LipmanDisposed 2000 @ 19.39View
2023-11-27Andrew D LipmanDisposed 2000 @ 17.11View
2023-11-03Andrew D LipmanDisposed 15400 @ 17.68View
2023-10-25Andrew D LipmanDisposed 2000 @ 19.23View
2023-09-25Andrew D LipmanDisposed 2000 @ 23.02View
2023-08-25Andrew D LipmanDisposed 2000 @ 23.33View
2023-08-21Laura NathansonDisposed 6068 @ 24.12View
2023-08-07Emma S BattleDisposed 1272 @ 26.15View
2023-07-25Andrew D LipmanDisposed 2000 @ 28.99View
2023-06-26Andrew D LipmanDisposed 2000 @ 32.12View
2023-05-25Andrew D LipmanDisposed 2000 @ 34.28View
2023-05-09Edwina D WoodburyDisposed 1255 @ 37.87View
2023-04-25Andrew D LipmanDisposed 2000 @ 40.75View
Monitoring Nu Skin's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nu Skin Enterprises. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.

Nu Skin's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Nu Skin's future performance. Based on our forecasts, it is anticipated that NUS will maintain a workforce of slightly above 3700 employees by May 2024.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Nu Skin Management Team Effectiveness

The company has Return on Asset of 0.0461 % which means that on every $100 spent on assets, it made $0.0461 of profit. This is way below average. Nu Skin's management efficiency ratios could be used to measure how well Nu Skin manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.01 in 2024. Return On Capital Employed is likely to drop to 0.04 in 2024. At this time, Nu Skin's Intangibles To Total Assets are comparatively stable compared to the past year. Asset Turnover is likely to gain to 1.84 in 2024, whereas Total Assets are likely to drop slightly above 1.2 B in 2024.
Common Stock Shares Outstanding is likely to gain to about 54.3 M in 2024. Net Income Applicable To Common Shares is likely to gain to about 135.7 M in 2024

Nu Skin Workforce Comparison

Nu Skin Enterprises is rated below average in number of employees category among related companies. The total workforce of Consumer Staples industry is now estimated at about 174,077. Nu Skin holds roughly 3,700 in number of employees claiming about 2.13% of stocks in Consumer Staples industry.

Nu Skin Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nu Skin insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nu Skin's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Nu Skin insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-03-01
1.0
10
10
 359,788 
 41,422 
2023-12-01
0.2
1
5
 35.00 
 30,470 
2023-09-01
0.3333
2
6
 8,355 
 13,546 
2023-06-01
1.1429
8
7
 29,641 
 9,816 
2023-03-01
0.7778
21
27
 387,889 
 308,466 
2022-12-01
0.625
5
8
 93,650 
 66,342 
2022-09-01
0.2727
3
11
 25,015 
 72,239 
2022-06-01
0.55
11
20
 52,530 
 129,771 
2022-03-01
1.4706
25
17
 372,658 
 125,128 
2021-12-01
0.5
1
2
 12.00 
 3,123 
2021-09-01
0.5
5
10
 37,781 
 56,178 
2021-06-01
0.7222
13
18
 63,276 
 99,446 
2021-03-01
0.7576
25
33
 510,119 
 138,295 
2020-12-01
0.3043
7
23
 43,410 
 97,593 
2020-09-01
0.4615
6
13
 30,011 
 80,000 
2020-06-01
7.0
14
2
 136,235 
 48,038 
2020-03-01
0.1818
2
11
 10,024 
 12,293 
2019-09-01
0.5
1
2
 11.00 
 278.00 
2019-06-01
1.0833
13
12
 47,278 
 49,432 
2019-03-01
1.125
27
24
 362,134 
 106,454 
2018-12-01
0.5
4
8
 7,508 
 15,000 
2018-09-01
0.5556
15
27
 57,606 
 111,628 
2018-06-01
0.7037
19
27
 51,543 
 160,387 
2018-03-01
1.1667
28
24
 1,771,962 
 6,193,339 
2017-12-01
0.3333
6
18
 118,607 
 340,605 
2017-09-01
0.5
7
14
 42,196 
 83,026 
2017-06-01
0.7826
18
23
 83,075 
 111,767 
2017-03-01
1.1333
17
15
 278,557 
 107,782 
2016-12-01
0.4545
5
11
 20,000 
 119,250 
2016-09-01
0.6667
2
3
 6,000 
 4,546,337 
2016-06-01
3.5
14
4
 57,782 
 28,738 
2016-03-01
0.9167
11
12
 1,309,950 
 476,352 
2015-12-01
8.0
8
1
 121,900 
 0.00 
2015-09-01
0.4
6
15
 136,000 
 289,272 
2015-06-01
4.3333
13
3
 46,186 
 14,386 
2015-03-01
0.75
12
16
 130,858 
 175,419 
2014-12-01
1.375
11
8
 192,700 
 204,556 
2014-09-01
0.6
3
5
 40,833 
 67,052 
2014-06-01
8.6667
26
3
 139,750 
 22,500 
2014-03-01
1.6316
31
19
 255,400 
 174,115 
2013-12-01
0.9375
30
32
 533,809 
 698,071 
2013-09-01
0.2
3
15
 13,334 
 138,173 
2013-06-01
2.8571
20
7
 151,002 
 213,750 
2013-03-01
1.36
34
25
 347,250 
 328,652 
2012-12-01
0.5
3
6
 35,000 
 22,445 
2012-09-01
3.6667
11
3
 146,252 
 430.00 
2012-06-01
1.625
26
16
 151,084 
 180,496 
2012-03-01
1.2903
40
31
 382,568 
 229,616 
2011-12-01
0.5714
4
7
 92,500 
 185,000 
2011-09-01
0.8462
22
26
 681,411 
 1,387,086 
2011-06-01
0.8444
38
45
 413,357 
 855,565 
2011-03-01
1.4375
23
16
 602,850 
 90,860 
2010-12-01
0.5263
10
19
 152,706 
 397,912 
2010-09-01
0.4138
12
29
 119,725 
 1,587,332 
2010-06-01
1.8
18
10
 104,850 
 4,895,308 
2010-03-01
0.5
12
24
 205,625 
 286,035 
2009-12-01
1.2308
16
13
 89,807 
 150,664 
2009-06-01
2.0
8
4
 77,500 
 82,489 
2009-03-01
3.6667
22
6
 447,951 
 4,715 
2008-09-01
0.1324
9
68
 68,650 
 231,535 
2008-06-01
6.5
13
2
 56,400 
 7,335 
2008-03-01
1.25
5
4
 42,450 
 7,566 
2007-12-01
5.0
20
4
 52,650 
 126,013 
2007-09-01
0.1875
3
16
 6,500 
 15,764 
2007-06-01
1.087
25
23
 142,400 
 191,818 
2007-03-01
0.2299
20
87
 97,700 
 517,143 
2006-12-01
0.0714
1
14
 18,000 
 1,350,850 
2006-09-01
1.8889
17
9
 97,200 
 395,100 
2006-06-01
6.6
66
10
 1,089,500 
 0.00 
2006-03-01
0.1818
2
11
 3.48 
 46,375 
2005-12-01
1.0
1
1
 0.51 
 57,475 
2005-09-01
0.8
20
25
 208,750 
 170,468 
2005-06-01
0.4706
16
34
 131,550 
 136,125 
2005-03-01
0.7391
17
23
 222,500 
 4,105,150 
2004-12-01
0.1667
1
6
 5,000 
 123,050 
2004-09-01
0.6329
50
79
 514,625 
 3,312,282 
2004-06-01
0.8333
5
6
 55,000 
 49,615 
2004-03-01
0.5263
20
38
 338,500 
 290,250 
2003-12-01
0.3953
17
43
 23,918,747 
 9,597,269 
2003-09-01
1.375
11
8
 240,002 
 2,807,375 

Nu Skin Notable Stakeholders

A Nu Skin stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Nu Skin often face trade-offs trying to please all of them. Nu Skin's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Nu Skin's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Truman HuntCEO and President and DirectorProfile
Ryan NapierskiPresident, Chief Executive Officer, DirectorProfile
Steven LundExecutive Chairman of the BoardProfile
Joseph ChangExecutive Vice President - Product Development, Chief Scientific OfficerProfile
Mark LawrenceChief Financial Officer, Executive Vice PresidentProfile
D DornyExecutive Vice President, General Counsel, SecretaryProfile
Scott SchwerdtPresident - Americas RegionProfile
Ritch WoodCFO, Principal Accounting Officer and VPProfile
Joe SueperSenior CTOProfile
Scott PondDirector - Investor RelationsProfile
Zhequing ShenDirectorProfile
Thomas PisanoIndependent DirectorProfile
Neil OffenIndependent DirectorProfile
Zheqing ShenIndependent DirectorProfile
Nevin AndersenIndependent DirectorProfile
Daniel CampbellLead Independent DirectorProfile
Edwina WoodburyIndependent DirectorProfile
Laura NathansonIndependent DirectorProfile
Andrew LipmanIndependent DirectorProfile
Matthew DornyVP, General Counsel and SecretaryProfile
Chayce ClarkExecutive Vice President General CounselProfile
Emma BattleDirectorProfile
Mark AdamsChief OfficerProfile
James ThomasChief Accounting OfficerProfile
Mang TangStrategic AdvisorProfile
Sandra TillotsonFounderProfile
Connie TangExecutive Vice President Chief Global Growth & customer Experience OfficerProfile
Blake RoneyFounderProfile

About Nu Skin Management Performance

The success or failure of an entity such as Nu Skin Enterprises often depends on how effective the management is. Nu Skin management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of NUS management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the NUS management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.01  0.01 
Return On Capital Employed 0.05  0.04 
Return On Assets 0  0 
Return On Equity 0.01  0.01 
The data published in Nu Skin's official financial statements usually reflect Nu Skin's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Nu Skin Enterprises. For example, before you start analyzing numbers published by NUS accountants, it's critical to develop an understanding of what Nu Skin's liquidity, profitability, and earnings quality are in the context of the Personal Care Products space in which it operates.
Please note, the presentation of Nu Skin's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Nu Skin's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Nu Skin's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Nu Skin Enterprises. Please utilize our Beneish M Score to check the likelihood of Nu Skin's management manipulating its earnings.

Nu Skin Workforce Analysis

Traditionally, organizations such as Nu Skin use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Nu Skin within its industry.

Nu Skin Manpower Efficiency

Return on Nu Skin Manpower

Revenue Per Employee532.2K
Revenue Per Executive70.3M
Net Income Per Employee2.3K
Net Income Per Executive307K
Working Capital Per Employee100.8K
Working Capital Per Executive13.3M
When determining whether Nu Skin Enterprises is a strong investment it is important to analyze Nu Skin's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nu Skin's future performance. For an informed investment choice regarding NUS Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nu Skin Enterprises. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Complementary Tools for NUS Stock analysis

When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Is Nu Skin's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nu Skin. If investors know NUS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nu Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.88)
Dividend Share
1.56
Earnings Share
0.17
Revenue Per Share
39.612
Quarterly Revenue Growth
(0.07)
The market value of Nu Skin Enterprises is measured differently than its book value, which is the value of NUS that is recorded on the company's balance sheet. Investors also form their own opinion of Nu Skin's value that differs from its market value or its book value, called intrinsic value, which is Nu Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nu Skin's market value can be influenced by many factors that don't directly affect Nu Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nu Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nu Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nu Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.